Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
Main Authors: | Roth J, Kassoumeri L, Patrick F, Ursu S, Holzinger D, Moncrieffe H, Wedderburn LR |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | Pediatric Rheumatology Online Journal |
Similar Items
-
Methotrexate in childhood arthritis: effects on gene expression
by: Moncrieffe H, et al.
Published: (2008-09-01) -
Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
by: Hirani SP, et al.
Published: (2008-09-01) -
Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
by: Hirani SP, et al.
Published: (2008-09-01) -
14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
by: Hunter PJ, et al.
Published: (2008-09-01) -
Regulatory T cells from the inflamed joints of patients with juvenile idiopathic arthritis (JIA) are dysregulated and display a pro-inflammatory profile
by: Nistala Kiran, et al.
Published: (2011-09-01)